| Dr Amanda Corey Porter, PSYD | |
|
1400 Jefferson Rd, Northfield, MN 55057-3081 | |
| (651) 241-0775 | |
| (651) 241-0772 |
| Full Name | Dr Amanda Corey Porter |
|---|---|
| Gender | Female |
| Speciality | Clinical Psychologist |
| Experience | 17 Years |
| Location | 1400 Jefferson Rd, Northfield, Minnesota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447217138 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | 2007030012 (Missouri) | Secondary |
| 103T00000X | Psychologist | LP5356 (Minnesota) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Allina Health System | 4587573613 | 3071 |
News Archive
Patients with bipolar disorder and their first-degree relatives exhibit deficits in sustained attention, study results show.
A study from four countries in Africa, published in The Lancet, shows that providing babies with up to 12 months of liquid formula HIV drugs, while breastfeeding with their HIV-positive mothers, is highly effective at protecting them from infection, including in the 6–12 month period after birth which has not been analysed in previous research.
Shire plc , the global specialty biopharmaceutical company, today announced that it has submitted a BLA with the FDA for REPLAGAL(R) (agalsidase alfa), its enzyme replacement therapy for Fabry disease. REPLAGAL first received marketing authorization in the European Union in 2001, and is approved for the treatment of Fabry disease in 45 countries.
Researchers at Children's Hospital Boston have developed a slow-release anesthetic drug-delivery system that could potentially revolutionize treatment of pain during and after surgery, and may also have a large impact on chronic pain management
› Verified 8 days ago
| Entity Name | Allina Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295272342 PECOS PAC ID: 4587573613 Enrollment ID: O20040319000460 |
News Archive
Patients with bipolar disorder and their first-degree relatives exhibit deficits in sustained attention, study results show.
A study from four countries in Africa, published in The Lancet, shows that providing babies with up to 12 months of liquid formula HIV drugs, while breastfeeding with their HIV-positive mothers, is highly effective at protecting them from infection, including in the 6–12 month period after birth which has not been analysed in previous research.
Shire plc , the global specialty biopharmaceutical company, today announced that it has submitted a BLA with the FDA for REPLAGAL(R) (agalsidase alfa), its enzyme replacement therapy for Fabry disease. REPLAGAL first received marketing authorization in the European Union in 2001, and is approved for the treatment of Fabry disease in 45 countries.
Researchers at Children's Hospital Boston have developed a slow-release anesthetic drug-delivery system that could potentially revolutionize treatment of pain during and after surgery, and may also have a large impact on chronic pain management
› Verified 8 days ago
| Entity Name | Allina Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457657249 PECOS PAC ID: 4587573613 Enrollment ID: O20221213001713 |
News Archive
Patients with bipolar disorder and their first-degree relatives exhibit deficits in sustained attention, study results show.
A study from four countries in Africa, published in The Lancet, shows that providing babies with up to 12 months of liquid formula HIV drugs, while breastfeeding with their HIV-positive mothers, is highly effective at protecting them from infection, including in the 6–12 month period after birth which has not been analysed in previous research.
Shire plc , the global specialty biopharmaceutical company, today announced that it has submitted a BLA with the FDA for REPLAGAL(R) (agalsidase alfa), its enzyme replacement therapy for Fabry disease. REPLAGAL first received marketing authorization in the European Union in 2001, and is approved for the treatment of Fabry disease in 45 countries.
Researchers at Children's Hospital Boston have developed a slow-release anesthetic drug-delivery system that could potentially revolutionize treatment of pain during and after surgery, and may also have a large impact on chronic pain management
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Amanda Corey Porter, PSYD 1400 Jefferson Rd, Northfield, MN 55057-3081 Ph: (651) 241-0775 | Dr Amanda Corey Porter, PSYD 1400 Jefferson Rd, Northfield, MN 55057-3081 Ph: (651) 241-0775 |
News Archive
Patients with bipolar disorder and their first-degree relatives exhibit deficits in sustained attention, study results show.
A study from four countries in Africa, published in The Lancet, shows that providing babies with up to 12 months of liquid formula HIV drugs, while breastfeeding with their HIV-positive mothers, is highly effective at protecting them from infection, including in the 6–12 month period after birth which has not been analysed in previous research.
Shire plc , the global specialty biopharmaceutical company, today announced that it has submitted a BLA with the FDA for REPLAGAL(R) (agalsidase alfa), its enzyme replacement therapy for Fabry disease. REPLAGAL first received marketing authorization in the European Union in 2001, and is approved for the treatment of Fabry disease in 45 countries.
Researchers at Children's Hospital Boston have developed a slow-release anesthetic drug-delivery system that could potentially revolutionize treatment of pain during and after surgery, and may also have a large impact on chronic pain management
› Verified 8 days ago
Barbara Anne Bofenkamp, MA LP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 220 Division St, Northfield, MN 55057 Phone: 507-645-9304 Fax: 507-645-6151 | |
Theresa M Melnychenko, MA, LP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 680 Professional Dr, Northfield, MN 55057 Phone: 507-663-0237 Fax: 507-663-1180 | |
Dr. Nathaniel Page, PHD, LP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2423 Valley Dr, Northfield, MN 55057 Phone: 801-471-8851 | |
Dr. Sylvia Jane Rinehart, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 220 Division St S, Northfield, MN 55057 Phone: 507-645-9304 Fax: 507-645-6151 | |
Robyn Gunderson, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 680 Professional Dr, Northfield, MN 55057 Phone: 507-663-0237 Fax: 507-663-1180 | |
Mr. Daniel John Dimick, MA, LP, LMFT Psychologist Medicare: Not Enrolled in Medicare Practice Location: 105 4th St E Ste 304, Northfield, MN 55057 Phone: 507-645-6575 | |
Elaine M Nesbit, MA LP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 220 Division St, Center For Human Resources, Northfield, MN 55057 Phone: 507-645-9304 Fax: 507-645-6151 |